Victor Hugo Freire, CEOThe regulatory pathway for products intended for human use and consumption in Latin America is inherently complex, driven by fragmented responsibilities among distributors and unclear post-registration obligations. This misalignment complicates market access for sanitarily regulated products, exposing manufacturers to delays, regulatory gaps and loss of control after approval.
How does CREIN support manufacturers entering Ecuador’s regulated health product market?
CREIN acts as a strategic legal and technical representative for manufacturers entering the Ecuadorian market for the first time and those progressively expanding their product portfolios. With deep expertise in the sanitary regulatory framework, the company manages registrations, coordinates regulatory processes and offers authorized representative services to ensure compliance beyond initial approval.
“We do not simply process registrations,” says Victor Hugo Freire, CEO. “We act as a representative, technical and regulatory partner, fully understanding our clients’ business models, product characteristics and target markets from the outset,”
CREIN’s operating model maintains continuity and regulatory stability throughout the regulatory lifecycle, enabling manufacturers to successfully thrive in the market. Clients value the firm’s emphasis on clarity, predictability and forward-looking regulatory decision-making. Regulatory timelines, documentation requirements and authority expectations are communicated upfront, helping clients avoid unplanned scenarios. When regulatory challenges arise, they are addressed through structured assessment and informed decision-making rather than reactive adjustments.
Full Regulatory Lifecycle Management
What operational pillars structure CREIN’s regulatory coordination and authority representation model?
CREIN’s differentiation is built on three strong pillars: Deep local and regional regulatory expertise, strong representation before the authorities, and proactive regulatory coordination that anticipates risks and optimizes timelines.
Involvement begins with early technical assessment and regulatory planning through approval, post-registration compliance and long-term regulatory governance. Before any submission is made, products are evaluated against Ecuadorian health classifications, regulatory criteria and documentation requirements. This early-stage analysis identifies gaps, potential objections and compliance risks that could delay or compromise approval.
CREIN prepares complete, compliant dossiers from the first filing, reducing observations, rework and avoidable delays during authority review. As a result, clients achieve measurable reductions in time-to-approval, improved regulatory predictability and faster access to their target markets.
Sanitary registration is managed in parallel with technical representation. By acting as the authorized regulatory representative, CREIN centralizes communication with health authorities and maintains consistency in submissions, responses and follow-up requirements. This eliminates fragmentation of responsibility across distributors or third parties and keeps regulatory information technically aligned and traceable throughout the process.
Registration ownership protection is a foundational element of CREIN’s regulatory representation approach. In the Ecuadorian market, manufacturers often lose control of their sanitary registrations while transferring ownership to local distributors. CREIN’s structure allows manufacturers to retain ownership while delegating regulatory management to a specialized, independent team. This preserves flexibility, enabling changes in commercial partnerships without jeopardizing regulatory status or market access.
-
We do not simply process registrations. We act as a representative, technical and regulatory partner, fully understanding our clients’ business models, product characteristics and target markets from the outset.
The responsibility does not end with approval. CREIN manages post-registration obligations, including renewals, variations and updates arising from regulatory changes. Clients receive guidance on how new requirements apply to their specific products and portfolios, along with clear timelines for implementation. This ongoing oversight reduces the risk of non-compliance, suspension or cancellation and supports sustained product availability.
Technical Representation in Non-Standard Regulatory Cases
Sustained regulatory continuity at CREIN is built on effective, formal engagement with health authorities. CREIN maintains communication with Ecuador’s regulatory bodies through official communication channels, including the Agency for Regulation, Control and Health Surveillance, based on technical credibility, consistent compliance and institutional respect. This supports clarification of regulatory criteria and facilitates efficient resolution of technical observations during evaluation.
Regulatory complexity increases when products fall outside established submission categories. CREIN has supported many clients in such cases. One involved a manufacturer with innovative medical devices that did not align clearly with existing regulatory categories. The challenge was not documentation but interpretation.
Through formal engagement channels, CREIN coordinated technical discussions involving the manufacturer and authority, providing expanded explanations of product functionality, intended use and risk profile. This approach enabled accurate evaluation while respecting the existing regulatory framework, reducing waiting times and preventing reprocessing or rejection.
Ongoing regulatory change introduces continuous compliance risk across registered product portfolios. CREIN maintains a structured regulatory monitoring system that tracks both proposed and finalized regulatory changes issued by health authorities. Each update is reviewed against existing registrations to determine whether technical files, labeling, storage conditions or representation structures require adjustment. Clients are informed in advance and supported through transition periods, using implementation timelines granted by authorities to adjust documentation or processes without disrupting operations.
“We help clients build sustainable regulatory models in which registration ownership, technical traceability and regulatory governance remain aligned with global business strategies,” says Freire.
Preserving Regulatory Control at Scale
How does CREIN maintain regulatory control across large product registration portfolios?
Regulatory precision defines how CREIN operates. Standardized regulatory frameworks, compliance matrices and technical controls allow multiple registrations to be managed simultaneously. Document traceability, deadline control and consistent technical criteria are maintained across expanding portfolios, reducing learning curves and approval risk.
For companies entering Ecuador for the first time, CREIN acts as a comprehensive regulatory partner, supporting market entry strategy, authorized representation and post-registration compliance planning. For established manufacturers, the focus shifts to orderly portfolio growth, regulatory maintenance and long-term continuity.
The benefit of this model is illustrated in the case of a medical device manufacturer with more than 100 registrations through multiple local distributors. When a key distributor ceased operations, the manufacturer faced immediate risk to its product portfolio and market presence.
CREIN conducted a comprehensive regulatory and operational assessment and assumed authorized technical representation. Following the compliant transfer of registrations, control was restored, and commercial operations continued without interruption. More than seven years later, the manufacturer continues to operate under the company’s regulatory governance model.
As regulatory frameworks continue to evolve, CREIN maintains its focus on representation, continuity and regulatory control. Its recognition as a Top Health Record Registry Services reflects the sustained implementation of structured regulatory governance that preserves sanitary registrations continuity and predictable market access.
